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Aims Haem oxygenase-1 (HO-1) is a haem-degrading enzyme that generates carbon monoxide, bilirubin, and iron ions.
Through these compounds, HO-1 mitigates cellular injury by exerting antioxidant, anti-apoptotic, and anti-inflamma-
tory effects. Here, we examined the influence of HO-1 deficiency and transient hypoxia/ischaemia-induced HO-1
overexpression on post-injury hindlimb recovery.
Methods
and results
Mice lacking functional HO-1 (HO-12/2) showed reduced reparative neovascularization in ischaemic skeletal
muscles, impaired blood flow (BF) recovery, and increased muscle cell death compared with their wild-type litter-
mates. Human microvascular endothelial cells (HMEC-1) transfected with plasmid vector (pHRE-HO-1) carrying
human HO-1 driven by three hypoxia response elements (HREs) and cultured in 0.5% oxygen demonstrated mark-
edly increased expression of HO-1. Such upregulated HO-1 levels were effective in conferring protection against
H2O2-induced cell death and in promoting the proangiogenic phenotype of HMEC-1 cells. More importantly,
when delivered in vivo, pHRE-HO-1 significantly improved the post-ischaemic foot BF in mice subjected to
femoral artery ligation. These effects were associated with reduced levels of pro-inflammatory cytokines (IL-6 and
CXCL1) and lower numbers of transferase-mediated dUTP nick-end labelling-positive cells. Moreover, HO-1 deliv-
ered into mouse skeletal muscles seems to influence the regenerative potential of myocytes as it significantly changed
the expression of transcriptional (Pax7, MyoD, myogenin) and post-transcriptional (miR-146a, miR-206) regulators of
skeletal muscle regeneration.
Conclusion Our results suggest the therapeutic potential of HO-1 for prevention of adverse effects in critical limb ischaemia.
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1. Introduction
Interruption of blood supply results in ischaemic injury which can
rapidly damage any tissue. Critical limb ischaemia, usually caused by
atherosclerotic plaques blocking the blood vessels, is a common
and devastating manifestation of peripheral arterial disease. It is asso-
ciated with a very high morbidity and mortality risk.1 In many cases,
the use of bypass surgery or balloon angioplasty is limited, necessitat-
ing amputation. For these reasons, the development of new therapies
continues to be an area of substantial scientific and clinical interest.
Haem oxygenase-1 (HO-1) degrades haem to carbon monoxide
(CO), biliverdin/bilirubin, and ferrous iron. These products, either dir-
ectly or indirectly, exert anti-oxidative, anti-apoptotic, and anti-
inflammatory effects.2 Proangiogenic properties of HO-1 appear to
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be mediated in large part by CO through the stimulation of soluble
guanylate cyclase in endothelial cells (ECs).3 Moreover, our latest
data demonstrate that HO-1 may be an important regulator of myo-
genic regulatory factors (MRFs) and microRNAs (miRNAs) involved in
myoblast differentiation.4 All of this makes HO-1 a promising candi-
date for gene therapy. Importantly, however, uncontrolled overex-
pression of HO-1 can cause serious detrimental side effects. The
release of high amounts of reactive iron under conditions of strongly
enhanced HO activity and a high supply of haem may potentially be
harmful to the cells.5 Therefore, creating a beneficial threshold of
this protein by its controlled expression seems to be crucial for
obtaining the therapeutic effects. This objective can be achieved
with hypoxia-regulated gene carriers.
Such an approach involves the naturally occurring mechanism, an
interaction of hypoxia-inducible factor-1 (HIF-1) with hypoxia re-
sponse element (HRE) what results in upregulation of the transgene
in pathologic hypoxic/ischaemic conditions. HIF-1 is a basic helix–
loop–helix heterodimeric transcription factor that consists of
oxygen-sensitive subunit HIF-1a or, in tissues such as the heart,
lungs, kidney and endothelium, HIF-2a and oxygen insensitive, consti-
tutively expressed subunit HIF-1b. It initiates the expression of several
hypoxia responsive genes, like erythropoietin, vascular endothelial
growth factor, or mouse HO-1.6 The main advantage of using
vectors containing HRE sequence is the induction of transgene ex-
pression only upon a drop in oxygen tension. Therefore, the produc-
tion of therapeutic agent is limited to the ischaemic region where its
presence might be beneficial. Additionally, when the tissue heals, it
becomes re-oxygenated and the transgene expression goes down.
Previously, hypoxia-regulated HO-1 gene transfer reduced cellular
damage during myocardial ischaemia–reperfusion (I/R) injury.7,8 More-
over, Tongers et al.9 demonstrated a significantly blunted blood flow
(BF) recovery after femoral artery ligation (FAL) in mice treated with
the HO inhibitor tin protoporphyrin-IX. However, as the protopor-
phyrin inhibitors of HO activity may exert many unspecific effects,
the genetic models are required to prove the role of HO-1 in revascu-
larization. Hence, to the best of our knowledge, in this study we tested
for the first time the importance of HO-1 in post-ischaemic neovascu-
larization and BF recovery in HO-1-deficient mice. Moreover, we gen-
erated and successfully used a plasmid harbouring human HO-1 driven
by three HRE sequences. We demonstrated anti-apoptotic, anti-
inflammatory, and proangiogenic action of HO-1, revealing additionally
the new mechanisms of its beneficial effect on muscle regeneration.
2. Methods
Detailed procedures and protocols are provided in the Supplementary
material online.
2.1 Reagents
Cell culture reagents, MCDB 131, and foetal bovine serum (FBS) were
from PAA (Lodz, Poland). Oligo(dT) primers, dNTPs, MMLV reverse tran-
scriptase, and lactate dehydrogenase (LDH) assay were obtained from
Promega (Gdansk, Poland). NCode miRNA First-Strand cDNA Synthesis
Kit was from Invitrogen. Propidium iodide (PI), mouse CXCL1-, mouse
IL-6-, and mouse TNFa-recognizing ELISA kits were procured from
R&D Systems (Warszawa, Poland). HMVEC-L Nucleofector Kit was
purchased from Lonza (Warszawa, Poland). Ketamine hydrochloride
(Bioketan) and xylazine hydrochloride (Sedazin) were from Biowet
(Pulawy, Poland). All other reagents and chemicals, unless otherwise
stated, were purchased from Sigma (Poznan, Poland).
2.2 Cell culture
Human microvascular endothelial cells (HMEC-1) were kindly provided by
Dr Francis Candal (Center for Disease Control and Prevention, Atlanta,
GA, USA) and cultured in the MCDB 131 medium containing 10%
heat-inactivated FBS, L-glutamine (2 mM), epidermal growth factor (10 ng/
mL) and hydrocortisone (1 mg/mL), penicillin (100 U/mL), and streptomycin
(10 mg/mL) at standard conditions: 378C, 5% CO2, and humidified atmos-
phere. For induction of HIF-1, the cells were placed in hypoxic chamber
(Billups Rothenberg), flushed with a low-oxygen gas mixture (containing
0.5% O2, 5% CO2, 94.5% N2) for 20 min. After flushing, gas ports were
tightly sealed and chambers were placed in the incubator at 378C. For
evaluation of cell survival, HMEC-1 cells were stimulated with 500 mM
hydrogen peroxide (H2O2) in the presence of 2% FBS.
2.3 Plasmids
The following plasmids were used in this study: pCMV-EGFP and
pCMV-HO-1—in in vitro experiments; pHRE-minCMV (pHRE-empty)
and pHRE-minCMV-HO-1 (pHRE-HO-1)—in in vitro and in vivo experi-
ments. cDNA for human HO-1 was obtained from cDNA library of
human keratinocytes (HaCaT) and subcloned into two vectors either
downstream of the cytomegalovirus (CMV) constitutive promoter
(pCMV-HO-1) or downstream of three copies of HRE
(5′-GACGTG-3′) and the minimal CMV promoter (pHRE-HO-1). This se-
quence enabled hypoxia-regulated gene expression.
2.4 Nucleofection of HMEC-1 cells
Cells were transfected under serum-free conditions with 2 mg of plasmid
DNA using the Nucleofector (Amaxa) and HMVEC-L Nucleofector Kit
according to vendor’s protocol. The transfection efficiency was deter-
mined 24 h later with Nikon Eclipse TS 1000 Fluorescence Microscope
by counting the cells expressing enhanced green fluorescent protein
(EGFP).
2.5 Western blotting
Protein extracts from transfected HMEC-1 cells and fragments of gastro-
cnemius muscles were prepared and analysed as previously described4
using antibodies and the conditions described in Supplementary material
online.
2.6 Analysis of cell death
Cell death after appropriate H2O2 treatment was analysed with (i) LDH
assay in the conditioned media according to vendor’s protocol and (ii)
red propidium iodide (PI) fluorescence.
2.7 Analysis of cell migration
Migratory properties of transfected HMEC-1 cells were analysed in (i)
scratch assay (cells were pre-treated with 5 mM hydroxyurea in order to
induce growth arrest) and (ii) Boyden chamber assay (transwell plates
with 8 mm pores coated with 20 mg/mL fibronectin mixed with 0.5%
gelatin in 1:1 ratio) according to the protocols described previously in
Grochot-Przeczek et al.10 and Jazwa et al.,11 respectively. After 12 h of
culture, scratches and transwell membranes were stained with haematoxy-
lin and eosin (H&E), photographed with Nikon Eclipse TS 1000 Microscope
at ×200 magnification, and analysed with the Image J software.
2.8 Murine hindlimb ischaemia and gene
delivery
All animal procedures were in accordance with the Directive 2010/63/EU
of the European Parliament and carried out under a license from the
Ethical Committee of the Jagiellonian University. Twelve-week-old male
and female HO-12/2 and HO-1+/+ mice of C57BL/6×FVB background
(courtesy of Dr Anupam Agarwal, Birmingham, USA) and 12-week-old
male C57/BL6 mice were used in the experiments. All animals were
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maintained under controlled environmental conditions (12 h light/dark
cycle at 238C), and provided with standard laboratory food and
water ad libitum. Unilateral FAL was performed by double ligation of
the superficial left femoral artery under either 2% isoflurane (Aerrane,
Baxter) gas anaesthesia (C57BL/6×FVB mice) or mixture of ketamine
hydrochloride (90 mg/kg) and xylazine hydrochloride (20 mg/kg) injected
intraperitoneally (C57BL/6 mice). The limb withdrawal response to toe
pinch was monitored to ensure the adequacy of anaesthesia. About
10–15 min before vessel ligation, pHRE-empty or pHRE-HO-1 was deliv-
ered into the left gastrocnemius muscle of each C57BL/6 mouse by three
injections (total dose 10 mg in 30 mL). Control animals were left untreat-
ed. BF was measured in anaesthetized animals up to 30 min after the
surgery and then at day 7 and day 14 using Laser Doppler Perfusion
Imager (LDPI) System (PIM II, Perimed). The ischaemic-to-non-ischaemic
foot BF ratio was calculated as an index of BF recovery. The readings of
individual measurements per mouse were averaged for each time point.
Animals were euthanized via an anaesthetic overdose (200 mg/kg of keta-
mine mixed with 40 mg/kg of xylazine delivered by intraperitoneal injec-
tion) at day 1 (to study the gene expression) and day 14 (to evaluate
the gene expression and vessel density) after surgery and gene transfer.
2.9 Histological analyses
Skeletal muscle sections were stained with H&E for overall morphology.
Microvessel density was evaluated in isolectin B4 (dilution 1:100, Vector
Laboratories) and CD31 (1:100, BD Biosciences) stained sections of 14
days post-ischaemic and intact mouse adductor skeletal muscles. Then, re-
spectively, streptavidin–fluorochrome-conjugated antibodies (Streptavi-
din Alexa Fluor 546) and rhodamine-conjugated anti-rat antibodies
(1:250, BD Biosciences) were used to visualize endothelial cells in the
muscle tissue. Apoptosis was determined in the gastrocnemius muscle
cryosections (6 mm) 1 day after gene transfer and/or FAL by transferase-
mediated dUTP nick-end labelling (TUNEL) staining (in situ cell death de-
tection kit Fluorescein, Roche, Indianapolis, IN, USA) according to
vendor’s protocol. Immunofluorescent staining against Pax-7 was per-
formed in the gastrocnemius muscle cryosections (6 mm) 14 days after
FAL and HO-1 gene transfer with the use of mouse anti-Pax7 antibody
(1:200; DSHB, University of Iowa) followed by secondary anti-mouse anti-
body Alexa Fluor 488 (1:250; Molecular Probes). The counting was per-
formed with the use of a fluorescent microscope (Nikon) at ×400
magnification.
2.10 Total RNA isolation
At 1 and 14 days post-gene transfer and/or FAL, fragments of gastrocne-
mius muscles were snap-frozen in liquid nitrogen and stored at 2808C.
Total RNA including small RNA fraction was isolated as previously
described4 by lysis in 1 mL of Qiazol Total RNA Isolation Reagent using
Tissue Lyzer (Qiagen).
2.11 RT–PCR evaluation of gene expression
and miRNA levels
RT–PCR was performed as previously described.4 cDNA template was
synthesized using NCode miRNA First-Strand cDNA Synthesis Kit follow-
ing the manufacturer protocol. Quantitative PCR (qPCR) was performed
using StepOne Plus Real-Time PCR (Applied Biosystems) in a mixture
containing SYBR Green PCR Master Mix (SYBR Green qPCR Kit), 50 ng
of cDNA and specific primers described in Supplementary Material
online. Relative quantification of gene expression was calculated based
on the comparative CT (threshold cycle value) method (DCT ¼ CT gene
of interest– CT housekeeping gene). Comparison of gene expression in different
samples was performed based on the differences in DCT of individual
samples (DDCT).
2.12 ELISA
The content of mouse CXCL1, IL-6, and TNFa in gastrocnemius muscle
homogenates was evaluated according to vendor’s protocol. After evaluation
of total protein contentwithBicinchoninicAcid ProteinAssayKit, the amount
of mouse CXCL1, IL-6, and TNFa was expressed in pg/mg protein.
2.13 Statistical analysis
Results are expressed as mean+ SEM unless otherwise stated. One-way
analysis of variance (ANOVA) followed by Bonferroni’s post hoc test or
unpaired Student’s t-test was used to evaluate the statistical significance
between investigated groups. P, 0.05was considered statistically significant.
3. Results
3.1 BF recovery and neovascularization
after hindlimb ischaemia is impaired in
HO-1-deficient mice
Immediately after the surgery (day 0), LDPI analysis demonstrated similar
reductions of blood perfusion inHO-1+/+ andHO-12/2 mice (Figure 1A
and B). Two weeks after the surgery, BF in ischaemic hindlimbs of
HO-1+/+ animals had almost returned to normal (Figure 1A and B),
whereas it was significantly impaired in HO-1-deficient mice (Figure 1A
and B). The number of capillaries was markedly increased in the 14
days post-ischaemic hindlimb adductor muscles of HO-1+/+ animals
when compared with intact muscles from untreated controls (Figure 1C
andD). Conversely, abolished angiogenic response to hindlimb ischaemia
was observed inmice lackingHO-1 (Figure 1C andD). Already 1 day post-
ischaemia, murine HO-1 mRNA levels detected in skeletal muscles of
HO-1+/+ animals were upregulated more than four times and we still
detected some induction at day 14 (Figure 1E). Accordingly, HO-12/2
mice submitted to the same treatment did not exhibit neither basal nor
ischaemia-induced HO-1 expression (Figure 1E). Moreover, in the 1 day
post-ischaemic skeletal muscle cross-sections of HO-12/2 mice, we
detected significantly higher numbers of TUNEL-positive cells when
compared with HO-1+/+ animals indicating an increased cell death and
muscle damage in the absence of HO-1 (Figure 1F).
3.2 Beneficial effects of HO-1
overexpressed in normoxic endothelial cells
To evaluate whether activation of HO-1 in ischaemic conditions may
have any functional consequences, we overexpressed HO-1 in
HMEC-1 cells growing in vitro and compared their angiogenic proper-
ties and survival under stressful conditions with control cells expres-
sing EGFP. HMEC-1 cells were chosen because in human cells,
particularly endothelial, in contrary to rodent cells the expression
of HO-1 is not induced and sometimes even downregulated under
hypoxic conditions.12,13 HMEC-1 cells were transfected by nucleofec-
tion with plasmids encoding EGFP (pCMV-EGFP) and human HO-1
(pCMV-HO-1). The transfection efficiency varied between 50 and
70% (Supplementary material online, Figure S1A). Accordingly,
western blot analysis performed 24 h after nucleofection revealed a
potent overexpression of human HO-1 in cells transfected with
pCMV-HO-1 (Figure 2A). Then, HMEC-1 cells overexpressing HO-1
and EGFP were subjected to H2O2-induced damage mimicking reper-
fusion injury. Incubation of control pCMV-EGFP-transfected HMEC-1
cells with graded concentrations of H2O2 for 24 h provoked a dose-
dependent decrease in the proportion of surviving cells (data not
shown). After 24 h of treatment with 500 mM H2O2, the level of
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LDH released by necrotic cells increased by about 50% and this H2O2
concentration was employed in all experiments investigating the pro-
survival effects of HO-1. The level of LDH released to the cell culture
media by pCMV-HO-1-transfected HMEC-1 cells treated with H2O2
was significantly lower when compared with the
pCMV-EGFP-transfected cells subjected to the same H2O2 treatment
(Figure 2B). Similar effect has been observed when cell death was
assessed with PI staining (Figure 2C). Moreover, overexpression of
HO-1 with pCMV-HO-1 vector markedly enhanced the migratory
potential of HMEC-1 cells evaluated in two different tests—scratch
assay (Figure 2D) and Boyden chamber assay (Figure 2E and Supple-
mentary material online, Figure S1B).
3.3 Beneficial effects of HO-1
overexpressed in hypoxic endothelial cells
Next, HMEC-1 cells were transfected by nucleofection with
pHRE-HO-1 or pHRE-empty vector. Western blot analysis revealed
potent overexpression of HO-1 in cells transfected with
pHRE-HO-1 and kept in hypoxia (Figure 3A, right panel) comparable
Figure 1 Post-ischaemic hindlimb perfusion and muscle vascularity is impaired in HO-12/2 mice. (A) Graph illustrates the time course of the re-
covery of BF to the ischaemic foot measured by Laser Doppler Flowmetry. (B) Images show typical Laser Doppler pictures of superficial BF in lower
limbs. Squares include the area of interest (the feet) in which average perfusion was computed by the software (1, ischaemic leg; 2, non-ischaemic leg).
Colour scale from blue to brown indicates progressive increases in BF. (C ) Graph illustrates total capillary density in HO-1+/+ (black bars) and
HO-12/2 (white bars) mice quantified 14 days after FAL and in untreated subjects. (D) Representative pictures from the immunofluorescent staining
detecting biotinylated isolectin B4 bound to endothelial cells. Magnification ×200. (E) qPCR for endogenous mouse HO-1 (mHO-1) normalized to
EF2. (F) Bar graphs show the numbers of TUNEL-positive apoptotic cells in the gastrocnemius muscle 1 day after FAL. Insets show representative
merged images of the muscle cross-sections stained for TUNEL (green) and nuclei (blue). Double positive cells are indicated by arrows. Magnification
×400. Values are means+ SEM of 4–6 animals per group and per time point. *P, 0.05 vs. HO-1+/+ at the appropriate time point. #P, 0.05 vs.
untreated HO-1+/+.
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with the one obtained after pCMV-HO-1 transfection (Figure 2A). LDH
released to the cell culturemedia by pHRE-HO-1-transfected HMEC-1
cells treated with 500 mM H2O2 in hypoxic conditions was mildly but
significantly lower when compared with the pHRE-empty vector-
transfected cells subjected to the same treatment (Figure 3B, right
panel). Moreover, pHRE-HO-1 transfection resulted in acceleration
of cell migration in hypoxic conditions (Figure 3C, right panel).
3.4 Administration of pHRE-HO-1
improves BF and reduces the incidence of
necrosis in ischaemic hindlimbs
On the basis of in vitro results, our next aim was to investigate whether
local overexpression of HO-1 will exert cytoprotective and proangio-
genic effects in vivo. Therefore, shortly before induction of unilateral
hindlimb ischaemia, we performed intramuscular injection of
pHRE-HO-1 construct encoding human HO-1 under the control of
three HRE sequences into the gastrocnemius muscle below the liga-
tion site. Control animals were injected with pHRE-empty vector.
The presence of human HO-1 mRNA in mouse gastrocnemius
muscle homogenates of pHRE-HO-1-injected animals was confirmed
by quantitative RT–PCR (Figure 4A) and at the protein level (Supple-
mentary material online, Figure S2A). Because available antibodies did
not allow to distinguish endogenous murine HO-1 from human HO-1,
the western blot analysis was done on samples collected from
HO-12/2 mice subjected to FAL and pHRE-HO-1 gene transfer (Sup-
plementary material online, Figure S2A). In wild-type mice, hindlimb is-
chaemia induced endogenous HO-1 expression 1 day after the insult
(Figure 4A). However, transfer of pHRE-HO-1 resulted in much stron-
ger expression of HO-1 in ischaemic muscles (Figure 4A). Accordingly,
overexpression of HO-1 resulted in a much better recovery of BF in
ischaemic hindlimbs at day 14 after the surgery and HO-1 gene trans-
fer than in control animals treated with pHRE-empty (Figure 4B and
Supplementary material online, Figure S2B). Moreover, this effect
was associated with decreased number of necrotic toes (1.5+ 0.5
vs. 2.5+ 0.9 in pHRE-empty-treated mice). Neovascularization in
the adductor muscles 14 days after insult was significantly increased
in the hindlimbs of mice treated with pHRE-HO-1, but not in
pHRE-empty-injected mice, when compared with untreated animals
(Figure 4C).
Figure 2 Beneficial effects of constitutive HO-1 overexpression on H2O2-induced mortality and migratory properties of HMEC-1 cells. (A)
Western blot demonstrating the overexpression of HO-1 in HMEC-1 cells transfected with pCMV-HO-1. HMEC-1 cells transfected with pCMV-EGFP
(black bars) or pCMV-HO-1 (white bars) were treated with 500 mM H2O2 for 24 h. Mortality was determined using (B) LDH assay and (C) PI staining
of cell nuclei. Migration of pCMV-EGFP- or pCMV-HO-1-transfected HMEC-1 cells was analysed in (D) scratch closure assay and (E) Boyden chamber
assay. Each bar represents mean+ SD of representative experiment performed three times in duplicates. *P, 0.05 vs. pCMV-EGFP under appro-
priate treatment.
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3.5 Administration of pHRE-HO-1
diminishes inflammatory response and
apoptosis in ischaemic skeletal muscles
Hindlimb ischaemia significantly increased production of
pro-inflammatory cytokines—murine functional homolog of human
IL-8 (CXCL1) and IL-6—already 1 day post-surgery (Figure 5A and
B, respectively). Importantly, injection of pHRE-HO-1 shortly before
FAL lowered the levels of both cytokines at day 1, although only
the inhibition of CXCL1 but not IL-6 (Figure 5A and B) nor TNFa
(data not shown) was statistically significant. Accordingly, the
general morphology analysis of the H&E stained transverse sections
of the 1 day post-ischaemic gastrocnemius muscle (Supplementary
material online, Figure S3) revealed smaller inflammatory cell infiltrates
in mice treated with pHRE-HO-1 when compared with
pHRE-empty-injected individuals (Supplementary material online,
Figure S3C vs. B). Importantly, HO-1 gene decreased also the
number of apoptotic TUNEL-positive cells already at day 1 post-
surgery (Figure 5C and Supplementary material online, Figure S2C),
providing evidence that local, transient HO-1 overexpression
improves skeletal muscle cell survival under ischaemic conditions.
3.6 Overexpression of HO-1 in skeletal
muscles modulates levels of molecules
involved in skeletal muscle regeneration
Postnatal growth and regeneration of skeletal muscle mainly depend
on adult muscle stem cells, named satellite cells. Activation of satellite
cells is governed by MRFs which appear to be regulated by HO-1.4
Accordingly, we observed about four-fold upregulation of MyoD
mRNA (Figure 6A) and also an increase in this protein levels (Supple-
mentary material online, Figure S4A and B), and about two-fold upre-
gulation of myogenin mRNA (Figure 6B) 1 day after ischaemia in
gastrocnemius muscles of animals treated with pHRE-empty. Slightly
lower levels of MyoD mRNA (Figure 6A, middle bars) and protein
(Supplementary material online, Figure S4B, middle bars) were
detected in mice overexpressing HO-1 at day 1 after FAL and were
accompanied by significant upregulation of Pax7 protein when com-
pared with 1 day post-ischaemic pHRE-empty-treated individuals
(Supplementary material online, Figure S4A). We have also detected
a significant decrease in myogenin mRNA levels (Figure 6B, middle
bars) in mice overexpressing HO-1 at 1 day after ischaemia. In con-
trast, after BF reconstitution at day 14 resulting in deactivation of
human HO-1 expression from the pHRE-HO-1 construct, much
higher mRNA levels of myogenin were detected in muscles injected
with pHRE-HO-1 than treated with pHRE-empty vector (Figure 6B,
right bars). Of note, no effect of transient HO-1 overexpression on
other myocyte differentiation-related genes (Mef2c, myocardin, and
desmin) has been found (data not shown).
MRFs control also the generation of myomirs, a set of conserved
miRNAs specific for skeletal muscles.14,15 Temporal upregulation of
myomirs negatively regulates the target genes, and is necessary for
proper muscle development.15 In the present study, we have
observed a significant increase in miR-206 (Figure 6C) in skeletal
muscles injected with pHRE-HO-1. Reversely, the expression of
miR-146a which may inhibit myoblast differentiation16 was downregu-
lated in pHRE-HO-1-transfected muscles (Figure 6D). In contrary, we
did not observe any significant differences between both groups of
animals in miR-1, miR-133a, and miR-133b levels (data not shown).
Additionally, we detected significantly lower levels of both Pax3
(Figure 6E) and Pax7 (Figure 6F, Supplementary material online,
Figure S4C) 14 days after the surgery in mice injected with
pHRE-HO-1 in comparison with pHRE-empty-treated controls.
Finally, the analysis of H&E-stained paraffin sections of 14 days post-
ischaemic skeletal muscles revealed that, in contrast to
pHRE-empty-treated individuals, mice subjected to pHRE-HO-1 gene
transfer formed many centrally nucleated fibres arising from muscle
satellite cells (Supplementary material online, Figure S3E and F).
4. Discussion
The salient finding of the present study is that hypoxia-regulated over-
expression of HO-1 accelerates the recovery of the ischaemic limbs,
Figure 3 Beneficial effects of hypoxia-induced HO-1 overexpres-
sion on H2O2-mediated mortality and migratory properties of
HMEC-1 cells. HMEC-1 cells transfected with pHRE-empty (black
bars) or pHRE-HO-1 (white bars) were cultured either in normoxic
(21% O2) or hypoxic (0.5% O2) conditions. (A) Western blot dem-
onstrating the overexpression of HO-1 in HMEC-1 cells transfected
with pHRE-HO-1 and kept in hypoxia (right panel). (B) LDH
detected in the conditioned media from HMEC-1 cells treated
with 500 mM H2O2 for 12 h. (C) Scratch closure assay was per-
formed on confluent monolayers of transfected HMEC-1 cells and
the scratch closure rate was determined by comparing the
denuded area immediately and 12 h later. Each bar represents
mean+ SD of representative experiment performed three times
in duplicates. *P, 0.05 vs. pHRE-empty at 12 h in hypoxia.
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the process potentially dependent on increased revascularization,
decreased inflammation, and improved muscle regeneration in
animals treated with HO-1 harbouring plasmid.
HO-1 is an inducible, cytoprotective enzyme that catabolizes haem
to free iron, CO, and biliverdin, which is converted to bilirubin.
Pharmacological inhibition of HO was previously shown to interfere
with the establishment of an SDF-1 gradient between the ischaemic
hindlimb and bone marrow, and the mobilization and recruitment
of putative EPCs defined as Sca-1+/Kdr+ cells.9 In the present
study, we have shown the diminished post-ischaemic reparative
neovascularization, increased muscle cell death, and impaired post-
ischaemic BF recovery in mice lacking the HO-1 gene.
It was previously shown that constitutive overexpression of HO-1
in mouse17 or rat18 ischaemic limbs improves the post-ischaemic BF
and promotes tissue survival. Unfortunately, however, iron ions, al-
though being capable of inducing protective ferritin,19 can also accel-
erate tissue injury via production of potentially harmful-free hydroxyl
radicals.5 Therefore, creating a beneficial threshold of HO-1 by its
controlled expression seems to be crucial for conferring the thera-
peutic effects, especially in terms of long-term protection.
Figure 4 Post-ischaemic BF is improved in mouse hindlimbs overexpressing HO-1. (A) Human HO-1 was significantly upregulated in gastrocnemius
muscles injected with pHRE-HO-1 1 day after FAL. (B) Graph illustrates the time course of the recovery of BF to the ischaemic foot measured by
Laser Doppler Flowmetry. (C ) Graph shows number of CD31-positive capillaries in the adductor muscles 14 days after FAL and gene transfer. Values
are means+ SEM of four animals per group and per time point. *P, 0.05 vs. pHRE-empty at day 14. #P, 0.05 vs. untreated.
Figure 5 HO-1 modulates inflammation and apoptosis in ischaemic skeletal muscles. ELISA for (A) CXCL1 chemokine—mouse homolog of human
IL-8 and (B) mouse IL-6. (C ) TUNEL-positive apoptotic cells in the gastrocnemius muscle 1 day after FAL and gene transfer. Values are means+ SEM
of four animals per group and per time point. *P, 0.05 vs. pHRE-empty at the appropriate time point.
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The concept of hypoxia-regulated HO-1 gene transfer was previ-
ously investigated as a suitable strategy for the treatment of cardiovas-
cular diseases by reducing cellular damage during I/R injury and
preserving heart function.7,20 Here, we show that such strategy can
be effective also in the treatment of acute limb ischaemia and, import-
antly, indicate for the other mechanisms of HO-1 effect, namely
enhanced revascularization and improved muscle regeneration. In
the present study, we delivered pHRE-HO-1 and the control
pHRE-empty vector into skeletal muscles by local injections. We
have detected human HO-1 mRNA already 1 day after surgical induc-
tion of ischaemia in mice, whereas 2 weeks later the transgene ex-
pression disappeared upon restoration of circulation. Therefore,
incorporation of hypoxia responsive elements in our pHRE-HO-1
construct provided a useful on–off physiological switch, which ren-
dered relatively fast transcription of the therapeutic gene dependent
on the hypoxic stimulus triggered by ischaemia.
Reactive oxygen species (ROS) play an important role in the patho-
physiology of ischaemic disease.7,8,21 Sudden occlusion of the blood
vessel often leads to I/R injury. It refers to paradoxical damage of
the tissue caused when blood supply returns to the tissue after a
period of ischaemia. It has been shown that HO-1 overexpression
may have a sparing effect on the ischaemic myocardium by reducing
(I/R)-induced injury and preventing the sequence of events leading
to cell loss and subsequent ventricular dysfunction.22 In the present
study, we have observed markedly better survival of HO-1 overex-
pressing ECs exposed to the high doses of H2O2. However, we did
not observe any significant differences between analysed groups of
mice neither in tissue ROS levels detected by dichlorodihydro-
fluorescein nor in DNA oxidation evaluated by 8-hydroxy-2′-
deoxyguanosine fluorescent staining (data not shown). These may
suggest that, unlike the I/R model, in which the tissue undergoes
repeated brief ischaemic episodes, the acute ischaemia is associated
with a more extensive injury that is not completely dependent on
ROS generation. Widespread activity of HO-1 and its products may
hence provide better protection in such conditions.
In the present study, we have shown that HO-1 gene transfer was
able to lower the pro-inflammatory IL-6 production by post-ischaemic
murine skeletal muscles. Similar effects of HO-1 were previously
Figure 6 HO-1 modulates levels of molecules involved in post-injury myocyte regeneration. qPCR for (A) MyoD, (B) myogenin, (C ) miR-206, (D)
miR-146a, (E) Pax3, and (F) Pax7. In (A), (B), (E), and (F) EF2 served as a constitutive control gene, in (C) and (D) snU6 served as a constitutive control.
Values are means+ SEM of four animals per group and per time point. *P, 0.05 vs. pHRE-empty at the appropriate time point.
A. Jazwa et al.122
by guest on Novem
ber 17, 2014
D
ow
nloaded from
 
observed in patients subjected to bypass surgery.23 The relationship
between HO-1 and IL-8 raises more controversy, because
HO-1-dependent24 as well as HO-1-independent13,25 changes in
IL-8 production were noted. In the present study, we have evaluated
the levels of chemokine CXCL1, which is a murine functional homo-
logue of human IL-8. CXCL1 was significantly lower upon HO-1 gene
delivery. It has been shown that pro-inflammatory markers correlate
with peripheral arterial disease progression and risk of amputation.26
Thus, the possibility of modulating the inflammatory response at the
site of injury with HO-1 may be beneficial.
It has also been shown that HO-1 might provide an anti-
inflammatory action in vivo through the downmodulation of cell adhe-
sion molecules accompanied by inhibition of leucocyte infiltration27
and via promotion of non-inflammatory angiogenesis facilitating
tissue repair.28 Importantly, our study shows another, new mechanism
of improved tissue repair by intramuscular HO-1 gene transfer. Acti-
vation of HO-1 was previously reported to induce osteoblast,29 bone
marrow mesenchymal stem cell,30 and monocyte31 differentiation,
whereas HO-1 haploinsufficiency led to disrupted erythroblast differ-
entiation.32 Satellite cells, the muscle progenitors, preserve the regen-
erative capacity of adult skeletal muscle. In response to muscle injury,
satellite cells become activated, proliferate, and fuse to either existing
muscle fibres or fuse together to form new muscle fibres.33 Here, we
showed that MyoD, as reported elsewhere,34 was strongly upregu-
lated shortly (1 day) after the surgery and its expression decreased
2 weeks later during the regeneration phase. Moreover, in the
present study, we have observed a slight decrease in MyoD and
more evident decrease in myogenin mRNA levels 1 day after
pHRE-HO-1 delivery and hypoxia/ischaemia-mediated activation of
human HO-1 expression. On the contrary, when HO-1 expression
in pHRE-HO-1-transfected murine hindlimbs has been switched-off
at day 14, the level of myogenin was significantly increased in compari-
son with muscles treated with control pHRE-empty vector. Accord-
ingly, Pax7 protein levels were higher in mice overexpressing HO-1
at 1 day after FAL when compared with empty vector-treated indivi-
duals. We propose that in this way, HO-1 may be implicated in the
early phases of myogenic differentiation and participate in the gener-
ation of a pool of reserve cells which are closely related to satellite
cells responsible for adult muscle regeneration. Indeed, our recent
study indicates that stable, long-term expression of HO-1 may
inhibit differentiation of myoblasts while increasing their proliferation.4
Hence, regulated expression of HO-1 in ischaemic limbs may exert
better effect than constitutive one.
In the present study, we have also evaluated the levels of muscle-
specific miRNAs. It is known that their generation can be modulated
by MRFs,15,35 and as our recent data indicate also by HO-1.4 We have
observed significant increase in miR-206, which promotes differenti-
ation,36 and decrease in miR-146a, known to inhibit myoblast differen-
tiation16 in skeletal muscles injected with pHRE-HO-1 when
compared with the control group 14 days post-treatment. Again,
switching-off the HO-1 expression after the period when it stimulates
myoblast proliferation may be beneficial and stimulate myoblast
differentiation.
Summing up, our study suggests that the effect of HO-1 on muscle
regeneration is multifactorial. First, it can be related to the known
cytoprotective action of HO-1, as reflected by decrease in apoptosis
of the muscle fibres in animals overexpressing HO-1 and attenuation
of inflammatory response in the injured tissue; second, the stimulation
of revascularization through the improvement of endothelial cell
viability, migration, and proliferation, resulting in increased formation
of capillaries; third, by the influence on myoblasts proliferation and dif-
ferentiation. It may be supposed that temporal expression of HO-1
initially promotes myoblasts proliferation, as suggested by increase
in Pax7 expression and decrease in MyoD and myogenin expression
at early phase of regeneration in muscle overexpressing HO-1.
Then switching off HO-1 expression may accelerate muscle differen-
tiation by downregulating the expression of Pax7 as well as miR-146a,
while stimulating the expression of differentiation drivers miR-206 and
myogenin.
In conclusion, our results demonstrate that HO-1 may play an im-
portant role in the protection of ischaemic tissue by decreasing in-
flammation and apoptosis, and promoting neovascularization.
Moreover, for the first time, we have shown that HO-1 may be an im-
portant new player in the muscular regeneration by promoting
renewal of the satellite cell compartment. The pHRE-HO-1 vector
provided a useful on–off physiological switch, which rendered rela-
tively fast transcription of the HO-1 gene in hypoxic/ischaemic condi-
tions and can be further investigated as a tool to provide
cytoprotection in ischaemic cardiovascular diseases.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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